BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1
909 results:

  • 1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Laversanne M; Sung H; Ferlay J; Siegel RL; Soerjomataram I; Jemal A
    CA Cancer J Clin; 2024; 74(3):229-263. PubMed ID: 38572751
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Robot-assisted versus laparoscopic pancreatoduodenectomy: a pan-European multicenter propensity-matched study.
    Emmen AMLH; Zwart MJW; Khatkov IE; Boggi U; Groot Koerkamp B; Busch OR; Saint-Marc O; Dokmak S; Molenaar IQ; D'Hondt M; Ramera M; Keck T; Ferrari G; Luyer MDP; Moraldi L; Ielpo B; Wittel U; Souche FR; Hackert T; Lips D; Can MF; Bosscha K; Fara R; Festen S; van Dieren S; Coratti A; De Hingh I; Mazzola M; Wellner U; De Meyere C; van Santvoort HC; Aussilhou B; Ibenkhayat A; de Wilde RF; Kauffmann EF; Tyutyunnik P; Besselink MG; Abu Hilal M;
    Surgery; 2024 Jun; 175(6):1587-1594. PubMed ID: 38570225
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Eco-friendly green synthesis of N‑pyrazole amino chitosan using PEG-400 as an anticancer agent against gastric cancer cells via inhibiting EGFR.
    Zhang L; Li C
    In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):365-373. PubMed ID: 38564118
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SERS-based AI diagnosis of lung and gastric cancer via exhaled breath.
    Xie X; Yu W; Wang L; Yang J; Tu X; Liu X; Liu S; Zhou H; Chi R; Huang Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jun; 314():124181. PubMed ID: 38527410
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.
    Ni M; Zhang Y; Sun Z; Zhou Q; Xiao J; Zhang B; Lin J; Gong B; Liu F; Meng F; Zheng G; Wang Y; Gu L; Li L; Shen W; Chen Y; Liu Y; Li L; Ling T; Cheng H
    Phytomedicine; 2024 May; 127():155496. PubMed ID: 38471368
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]    [Full Text] [Related]  

  • 7. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
    Yau T; Kaseb A; Cheng AL; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Milwee S; Wang Z; Curran D; Kelley RK; Rimassa L
    Lancet Gastroenterol Hepatol; 2024 Apr; 9(4):310-322. PubMed ID: 38364832
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. First clinical experiences of robotic gastrectomy for gastric cancer using the hinotori™ surgical robot system.
    Inoue S; Nakauchi M; Umeki Y; Suzuki K; Serizawa A; Akimoto S; Watanabe Y; Tanaka T; Shibasaki S; Inaba K; Uyama I; Suda K
    Surg Endosc; 2024 Mar; 38(3):1626-1636. PubMed ID: 38332175
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. cancer burden and risk in the Chinese population aged 55 years and above: A systematic analysis and comparison with the USA and Western Europe.
    Gao TY; Tao YT; Li HY; Liu X; Ma YT; Li HJ; Xian-Yu CY; Deng NJ; Leng WD; Luo J; Zhang C
    J Glob Health; 2024 Jan; 14():04014. PubMed ID: 38271210
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Enantiomer-Specific Colorimetric Tandem Assays for Salivary d-Alanine Associated with gastric cancer.
    Liu C; Wu Y; Li M; Liu F; Kong P; Yang H; Liu X
    Anal Chem; 2024 Feb; 96(5):1906-1912. PubMed ID: 38251936
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
    Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
    Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Safety and Pharmacokinetic Assessment of the FIC CLDN18.2/4-1BB Bispecific Antibody in Rhesus Monkeys.
    Wang J; Dong T; Gong X; Li D; Sun J; Luo Y; Wu H
    Int J Toxicol; 2024; 43(3):291-300. PubMed ID: 38115178
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multicentre positive deviance seminar to generate best practice recommendations to reduce anastomotic leak and length of stay for patients undergoing oesophagectomy.
    Jones D; Gingrich M; Anstee C; Najmeh S; Safieddine N; Darling G; Malthaner R; Finley C; French DG; Ferri L; Seely A
    BMJ Open Qual; 2023 Dec; 12(4):. PubMed ID: 38114245
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Short- and long-term outcomes of robotic versus open radical antegrade modular pancreatosplenectomy: a retrospective propensity score-matched cohort study.
    Song Y; Zou W; Gao Y; Zhao Z; Yin Z; Xiao C; Liu Q; Liu R
    Surg Endosc; 2024 Mar; 38(3):1316-1328. PubMed ID: 38110793
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Application of single-layer continuous duct-to-mucosa pancreaticojejunostomy with two figure-of-eight sutures in total laparoscopic pancreaticoduodenectomy.
    Li D; Du C; Zhao W; Li S; Lv H; Wang W
    Langenbecks Arch Surg; 2023 Nov; 408(1):434. PubMed ID: 37949977
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors.
    Leidner R; Conlon K; McNeel DG; Wang-Gillam A; Gupta S; Wesolowski R; Chaudhari M; Hassounah N; Lee JB; Ho Lee L; O'Keeffe JA; Lewis N; Pavlakis GN; Thompson JA
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37907221
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
    Milito C; Pulvirenti F; Garzi G; Sculco E; Cinetto F; Firinu D; Lagnese G; Punziano A; Discardi C; Costanzo G; Felice C; Spadaro G; Ferrari S; Quinti I
    Front Immunol; 2023; 14():1231242. PubMed ID: 37868983
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
    Beihaghi M; Sahebi R; Beihaghi MR; Nessiani RK; Yarasmi MR; Gholamalizadeh S; Shahabnavaie F; Shojaei M
    BMC Cancer; 2023 Oct; 23(1):985. PubMed ID: 37845622
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in cancer Burden, 2020-2050: A Statistical Modeling Study.
    Nguyen PT; Hori M; Matsuda T; Katanoda K
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1756-1770. PubMed ID: 37756571
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
    He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
    Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 46.